Cyclin Dependent Kinase 1 Market Report

Global and Region Cyclin Dependent Kinase 1 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：188
  • REPORT CODE：GMM986564
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cyclin Dependent Kinase 1 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cyclin Dependent Kinase 1market, defines the market attractiveness level of Cyclin Dependent Kinase 1 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cyclin Dependent Kinase 1 industry, describes the types of Cyclin Dependent Kinase 1 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cyclin Dependent Kinase 1 market and the development prospects and opportunities of Cyclin Dependent Kinase 1 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cyclin Dependent Kinase 1 market in Chapter 13.

    By Player:

    • Astex Pharmaceuticals Inc

    • ChoDang Pharm Co Ltd

    • Presage Biosciences Inc

    • Tiziana Life Sciences Plc

    • Tragara Pharmaceuticals Inc

    By Type:

    • AT-7519

    • CD-650

    • Milciclib

    • Others

    By End-User:

    • Relapsed Chronic Lymphocytic Leukemia

    • Gliosarcoma

    • Lymphoma

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cyclin Dependent Kinase 1 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cyclin Dependent Kinase 1 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cyclin Dependent Kinase 1 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cyclin Dependent Kinase 1 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cyclin Dependent Kinase 1 Market Analysis and Outlook to 2022

    • 7.1 Global Cyclin Dependent Kinase 1 Consumption (2017-2022)

    • 7.2 United States Cyclin Dependent Kinase 1 Consumption (2017-2022)

    • 7.3 Europe Cyclin Dependent Kinase 1 Consumption (2017-2022)

    • 7.4 China Cyclin Dependent Kinase 1 Consumption (2017-2022)

    • 7.5 Japan Cyclin Dependent Kinase 1 Consumption (2017-2022)

    • 7.6 India Cyclin Dependent Kinase 1 Consumption (2017-2022)

    • 7.7 South Korea Cyclin Dependent Kinase 1 Consumption (2017-2022)

    8 Region and Country-wise Cyclin Dependent Kinase 1 Market Analysis and Outlook to 2028

    • 8.1 Global Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    • 8.2 United States Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    • 8.3 Europe Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    • 8.4 China Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    • 8.5 Japan Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    • 8.6 India Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    • 8.7 South Korea Cyclin Dependent Kinase 1 Consumption Forecast (2022-2028)

    9 Global Cyclin Dependent Kinase 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Cyclin Dependent Kinase 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AT-7519 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CD-650 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Milciclib Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cyclin Dependent Kinase 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Relapsed Chronic Lymphocytic Leukemia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Gliosarcoma Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cyclin Dependent Kinase 1 Market Outlook by Types and Applications to 2028

    • 10.1 Global Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AT-7519 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CD-650 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Milciclib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Relapsed Chronic Lymphocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Gliosarcoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cyclin Dependent Kinase 1 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cyclin Dependent Kinase 1 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cyclin Dependent Kinase 1 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cyclin Dependent Kinase 1 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cyclin Dependent Kinase 1 Market Competitive Analysis

    • 14.1 Astex Pharmaceuticals Inc

      • 14.1.1 Astex Pharmaceuticals Inc Company Details

      • 14.1.2 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product and Service

    • 14.2 ChoDang Pharm Co Ltd

      • 14.2.1 ChoDang Pharm Co Ltd Company Details

      • 14.2.2 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product and Service

    • 14.3 Presage Biosciences Inc

      • 14.3.1 Presage Biosciences Inc Company Details

      • 14.3.2 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Product and Service

    • 14.4 Tiziana Life Sciences Plc

      • 14.4.1 Tiziana Life Sciences Plc Company Details

      • 14.4.2 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product and Service

    • 14.5 Tragara Pharmaceuticals Inc

      • 14.5.1 Tragara Pharmaceuticals Inc Company Details

      • 14.5.2 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cyclin Dependent Kinase 1

    • Figure Cyclin Dependent Kinase 1 Picture

    • Table Global Cyclin Dependent Kinase 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cyclin Dependent Kinase 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cyclin Dependent Kinase 1 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cyclin Dependent Kinase 1 Consumption by Country (2017-2022)

    • Figure United States Cyclin Dependent Kinase 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Cyclin Dependent Kinase 1 Consumption and Growth Rate (2017-2022)

    • Figure China Cyclin Dependent Kinase 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Cyclin Dependent Kinase 1 Consumption and Growth Rate (2017-2022)

    • Figure India Cyclin Dependent Kinase 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cyclin Dependent Kinase 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Cyclin Dependent Kinase 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cyclin Dependent Kinase 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AT-7519 Consumption and Growth Rate (2017-2022)

    • Figure Global CD-650 Consumption and Growth Rate (2017-2022)

    • Figure Global Milciclib Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Relapsed Chronic Lymphocytic Leukemia Consumption and Growth Rate (2017-2022)

    • Figure Global Gliosarcoma Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AT-7519 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CD-650 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Milciclib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Relapsed Chronic Lymphocytic Leukemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gliosarcoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cyclin Dependent Kinase 1 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cyclin Dependent Kinase 1 Export by Region (Top 5 Countries) (2017-2028)

    • Table Astex Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product and Service

    • Table ChoDang Pharm Co Ltd (Foundation Year, Company Profile and etc.)

    • Table ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product and Service

    • Table Presage Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Presage Biosciences Inc Cyclin Dependent Kinase 1 Product and Service

    • Table Tiziana Life Sciences Plc (Foundation Year, Company Profile and etc.)

    • Table Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product and Service

    • Table Tragara Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US